Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105875061 | 10587506 | 1 | I | 20141030 | 20141104 | 20141117 | 20141117 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-53134BP | BOEHRINGER INGELHEIM | 65.33 | YR | F | Y | 70.31000 | KG | 20141117 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105875061 | 10587506 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | INHALATION | 18 MCG | D | 404458B | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | ||||
| 105875061 | 10587506 | 2 | C | LYRICA | PREGABALIN | 1 | ORAL | 600 MG | D | 0 | 300 | MG | CAPSULE | BID | |||||
| 105875061 | 10587506 | 3 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | ORAL | 200 MG | D | 0 | 100 | MG | TABLET | QD | |||||
| 105875061 | 10587506 | 4 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | ORAL | 100 MG | D | 0 | 100 | MG | TABLET | QD | |||||
| 105875061 | 10587506 | 5 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | ORAL | 60 MG | D | 0 | 10 | MG | TABLET | ||||||
| 105875061 | 10587506 | 6 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | D | 0 | |||||||||||
| 105875061 | 10587506 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | ORAL | 20 MG | D | 0 | 10 | MG | TABLET | BID | |||||
| 105875061 | 10587506 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | ORAL | 40 MG | D | 0 | 40 | MG | CAPSULE | QD | |||||
| 105875061 | 10587506 | 9 | C | ASPIRIN. | ASPIRIN | 1 | ORAL | 81 MG | D | 0 | 81 | MG | TABLET | QD | |||||
| 105875061 | 10587506 | 10 | C | LOVASTATIN. | LOVASTATIN | 1 | ORAL | 20 MG | D | 0 | 20 | MG | TABLET | QD | |||||
| 105875061 | 10587506 | 11 | C | LASIX | FUROSEMIDE | 1 | ORAL | 40 MG | D | 0 | 20 | MG | TABLET | BID | |||||
| 105875061 | 10587506 | 12 | C | CARISOPRODOL. | CARISOPRODOL | 1 | ORAL | D | 0 | 350 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105875061 | 10587506 | 1 | Chronic obstructive pulmonary disease |
| 105875061 | 10587506 | 2 | Nerve injury |
| 105875061 | 10587506 | 3 | Anxiety |
| 105875061 | 10587506 | 5 | Pain in extremity |
| 105875061 | 10587506 | 6 | Back pain |
| 105875061 | 10587506 | 7 | Hypertension |
| 105875061 | 10587506 | 8 | Nodule |
| 105875061 | 10587506 | 9 | Product used for unknown indication |
| 105875061 | 10587506 | 10 | Blood cholesterol increased |
| 105875061 | 10587506 | 11 | Peripheral swelling |
| 105875061 | 10587506 | 12 | Muscle spasms |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105875061 | 10587506 | Blood pressure increased | |
| 105875061 | 10587506 | Fatigue | |
| 105875061 | 10587506 | Hypersomnia | |
| 105875061 | 10587506 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105875061 | 10587506 | 1 | 2012 | 0 | ||
| 105875061 | 10587506 | 2 | 2013 | 0 | ||
| 105875061 | 10587506 | 3 | 2008 | 0 | ||
| 105875061 | 10587506 | 4 | 2008 | 0 | ||
| 105875061 | 10587506 | 5 | 2010 | 0 | ||
| 105875061 | 10587506 | 7 | 1994 | 0 | ||
| 105875061 | 10587506 | 8 | 2004 | 0 | ||
| 105875061 | 10587506 | 10 | 1994 | 0 |